NEW YORK (GenomeWeb News) - DNAStar said yesterday that Cancer Research UK has expanded its site license for the company’s Lasergene sequence analysis software.
In November, CR-UK licensed Lasergene for use at its Lincoln’s Inn Field and Clare Hall laboratories.
The new three-year agreement allows the Cambridge Research Institute and the Paterson Institute for Cancer Research to use the software at their labs as well.
GATC Biotech is DNAStar’s distributor for European markets.
Financial terms of the agreement were not released.